Timothy Morris
2020
In 2020, Timothy Morris earned a total compensation of $1.5M as Chief Operating and Financial Officer at KaloBios Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $88,342 |
|---|---|
| Option Awards | $1,150,002 |
| Salary | $197,917 |
| Other | $38,500 |
| Total | $1,474,761 |
Morris received $1.2M in option awards, accounting for 78% of the total pay in 2020.
Morris also received $88.3K in non-equity incentive plan, $197.9K in salary and $38.5K in other compensation.
Rankings
In 2020, Timothy Morris' compensation ranked 6,894th out of 13,090 executives tracked by ExecPay. In other words, Morris earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,894 out of 13,090 | 47th |
Division Manufacturing | 2,878 out of 5,621 | 49th |
Major group Chemicals And Allied Products | 1,164 out of 2,254 | 48th |
Industry group Drugs | 1,002 out of 1,954 | 49th |
Industry Pharmaceutical Preparations | 746 out of 1,459 | 49th |
Source: SEC filing on April 23, 2021.
Morris' colleagues
We found three more compensation records of executives who worked with Timothy Morris at KaloBios Pharmaceuticals in 2020.